Hussman Strategic Advisors Inc. Buys New Shares in Doximity, Inc. $DOCS

Hussman Strategic Advisors Inc. purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS) during the second quarter, HoldingsChannel.com reports. The fund purchased 52,500 shares of the company’s stock, valued at approximately $3,220,000.

Several other institutional investors also recently made changes to their positions in DOCS. GAMMA Investing LLC raised its position in shares of Doximity by 5.9% in the 2nd quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock worth $183,000 after buying an additional 165 shares during the period. Louisiana State Employees Retirement System increased its stake in Doximity by 0.5% during the second quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock worth $2,306,000 after acquiring an additional 200 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Doximity by 0.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares during the period. Greenleaf Trust lifted its stake in shares of Doximity by 5.4% in the 1st quarter. Greenleaf Trust now owns 4,492 shares of the company’s stock valued at $261,000 after purchasing an additional 230 shares in the last quarter. Finally, Stephens Inc. AR grew its holdings in shares of Doximity by 6.0% during the 2nd quarter. Stephens Inc. AR now owns 4,603 shares of the company’s stock worth $282,000 after purchasing an additional 259 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Trading Up 1.4%

NASDAQ DOCS opened at $66.91 on Tuesday. The stock has a market cap of $12.53 billion, a P/E ratio of 66.91, a PEG ratio of 4.10 and a beta of 1.38. The company’s fifty day simple moving average is $69.77 and its 200-day simple moving average is $62.49. Doximity, Inc. has a 52 week low of $41.34 and a 52 week high of $85.21.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the prior year, the business posted $0.28 EPS. Doximity’s revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on DOCS shares. Evercore ISI raised their price target on shares of Doximity from $75.00 to $81.00 and gave the company an “outperform” rating in a report on Wednesday, October 8th. Wells Fargo & Company increased their price objective on shares of Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Monday, August 4th. Bank of America raised shares of Doximity from a “neutral” rating to a “buy” rating and raised their target price for the company from $75.00 to $82.00 in a research note on Monday, October 27th. Truist Financial lifted their target price on shares of Doximity from $52.00 to $61.00 and gave the company a “hold” rating in a report on Thursday, July 17th. Finally, KeyCorp increased their price target on Doximity from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $70.42.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the sale, the director directly owned 3,221 shares in the company, valued at $241,575. The trade was a 86.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Regina M. Benjamin sold 5,000 shares of the company’s stock in a transaction that occurred on Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the transaction, the director directly owned 19,839 shares in the company, valued at approximately $1,405,394.76. The trade was a 20.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 35,000 shares of company stock worth $2,521,700. Corporate insiders own 31.30% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.